Rare Endocrine Disorders icon in white

Rare Endocrine Disorders

Explore facts and recommendations for pharmacological treatments for rare endocrine disorders.

pharmacotherapies
Filters

We are still gathering material for this library.

Please check again soon.

We're sorry

We didn't find any resources that match your selection.

Please adjust your filter(s) and try again.

pharmacotherapies
 
rare endocrine disorders Video

Mechanisms of Action of Long-Acting Growth Hormone Preparations in Children with Growth Hormone Deficiency (IME Content)

Whiteboard animation of various long-acting treatment options for pediatric growth hormone deficiency.

Watch video
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
pharmacotherapies
 
Preview
rare endocrine disorders PDF

Sogroya® vs. Once-daily Growth Hormone - Phase 3 Pediatric Patients with Growth Hormone Deficiency (REAL 4)

Results of REAL 4, the pivotal Phase 3 trial investigating efficacy and safety of once-weekly Sogroya® compared to once daily Norditropin® in growth-hormone naïve pre-pubertal children with growth hormone deficiency.

Download
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
pharmacotherapies
 
Preview
rare endocrine disorders PDF

Sogroya® vs. Once-daily Growth Hormone - Phase 2 Pediatric Patients with Growth Hormone Deficiency (REAL 3)

Overview of REAL 3, the Phase 2 dose-finding trial investigating efficacy and safety of once-weekly Sogroya® compared to once daily Norditropin® FlexPro® injection in growth-hormone naïve pre-pubertal children with growth hormone deficiency.

Download
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
pharmacotherapies
 
Preview
rare endocrine disorders PDF

Sogroya® Treatment-naive Adults with Growth Hormone Deficiency (REAL 1)

Summary of REAL 1, the pivotal Phase 3 study evaluating the efficacy and safety of once-weekly Sogroya® compared to once-weekly placebo or once-daily Norditropin® in adults with growth hormone deficiency.

Download
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
pharmacotherapies
 
Preview
rare endocrine disorders PDF

Albumin Interactions with Sogroya®

An overview of expected albumin interactions from hypoalbuminemia or other protein-bound drugs based on the mechanism of protraction (albumin-binding) used by Sogroya®

Download
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
pharmacotherapies
 
Preview
rare endocrine disorders PDF

Growth Hormone Deficiency Practice Aids (IME Content)

Various practice aids for HCPs, including a chart detailing the patient experience / perspective, a 9-item shared decision-making questionnaire, and information and questionnaire pertaining to the LAuGH clinical trial / enrollment evaluation,

Download
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
pharmacotherapies
 
Preview
rare endocrine disorders PDF

Growing Pains: Overcoming Challenges in the Management of Adult Growth Hormone Deficiency (IME content)

Overview of adult growth hormone deficiency, available and emerging treatment options, and healthcare transition challenges with long-term management

Download
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close
continuing education icon

Continuing Education

Find accredited opportunities in rare endocrine education.

Explore CE Activities
pharmacotherapies
 
rare endocrine disorders Video

Sogroya® Mechanism of Action

This video discusses the mechanism of action of Sogroya®

Watch video
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close

Rare Endocrine Disorders

disease education
View Resources

Rare Endocrine Disorders

congress materials
View Resources

Looking for additional resources?
Explore other libraries or search the Exchange.

Novo Nordisk® Scientific Exchange logo

Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

This medical content was developed independently by a third party via an educational grant. This material is copyright protected and is provided here with permission for educational and informational purposes only and is not certified for continuing education credits.

Continue

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

Continue

GATED INTERSTITAL  

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

ACCESS DENIED

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.